Cargando…
ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia
Autores principales: | Virely, Clemence, Gasparoli, Luca, Mangolini, Maurizio, Clesham, Katherine, Inglott, Sarah, Edwards, Darren, Adams, Stuart, Bartram, Jack, Samarasinghe, Sujith, Ancliff, Philip, Vora, Ajay, de Boer, Jasper, Williams, Owen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489581/ https://www.ncbi.nlm.nih.gov/pubmed/32984770 http://dx.doi.org/10.1097/HS9.0000000000000467 |
Ejemplares similares
-
Identification of a c-MYB-directed therapeutic for acute myeloid leukemia
por: Clesham, Katherine, et al.
Publicado: (2022) -
Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia
por: O’Connor, David, et al.
Publicado: (2018) -
Fluorescence in situ Hybridization Analysis of 12;21 Translocation in Japanese Childhood Acute Lymphoblastic Leukemia
por: Eguchi‐Ishimae, Minenori, et al.
Publicado: (1998) -
The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21)
por: Kaczmarska, Agnieszka, et al.
Publicado: (2023) -
1221. Evaluation of the FilmArray® Global Fever Panel
por: Helm, Jared R, et al.
Publicado: (2020)